Skip to content

Syndax Pharmaceuticals, Inc.: filings

Every Syndax Pharmaceuticals, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 42 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-04fiscal Q2 2026391140001193125-26-332750
10-Q2026-04-30fiscal Q1 202639800001193125-26-197154
10-K2026-02-26fiscal FY 2025471180001193125-26-076536
10-Q2025-11-03fiscal Q3 2025361100001193125-25-262521
10-Q2025-08-04fiscal Q2 2025351020000950170-25-101985
10-Q2025-05-05fiscal Q1 202535720000950170-25-063518
10-K2025-03-03fiscal FY 2024461180000950170-25-030394
10-Q2024-11-05fiscal Q3 2024351100000950170-24-121439
10-Q2024-08-01fiscal Q2 2024341040000950170-24-089241
10-Q2024-05-08fiscal Q1 202433680000950170-24-055053
10-K2024-02-27fiscal FY 2023431090000950170-24-021253
10-Q2023-11-02fiscal Q3 2023351100000950170-23-058165
10-Q2023-08-03fiscal Q2 2023351060000950170-23-037943
10-Q2023-05-08fiscal Q1 202335720000950170-23-018806
10-K2023-02-28fiscal FY 2022441100000950170-23-005079
10-Q2022-11-03fiscal Q3 2022361100000950170-22-021848
10-Q2022-08-08fiscal Q2 2022361050000950170-22-015523
10-Q2022-05-09fiscal Q1 202231620001564590-22-018873
10-K2022-03-01fiscal FY 2021451080001564590-22-008112
10-Q2021-11-15fiscal Q3 202133950001564590-21-057004
10-Q2021-08-09fiscal Q2 202133920001564590-21-042657
10-Q2021-05-11fiscal Q1 202133670001564590-21-026548
10-K2021-03-12fiscal FY 2020391550001564590-21-012607
10-Q2020-11-05fiscal Q3 202034960001564590-20-051287
10-Q2020-08-06fiscal Q2 202034920001564590-20-037777
10-Q2020-05-07fiscal Q1 202033660001564590-20-022971
10-K2020-03-05fiscal FY 2019381510001564590-20-009016
10-Q2019-11-07fiscal Q3 201934960001564590-19-041719
10-Q2019-08-07fiscal Q2 201934920001564590-19-030067
10-Q2019-05-08fiscal Q1 201934680001564590-19-017318
10-K2019-03-07fiscal FY 2018361480001564590-19-006772
10-Q2018-11-05fiscal Q3 201833860001564590-18-026892
10-Q2018-08-08fiscal Q2 201833840001564590-18-020483
10-Q2018-05-09fiscal Q1 201828570001564590-18-012378
10-K2018-03-08fiscal FY 2017291230001564590-18-004911
10-Q2017-11-08fiscal Q3 201727730001193125-17-336444
10-Q2017-08-10fiscal Q2 201727710001193125-17-254597
10-Q2017-05-09fiscal Q1 201726530001193125-17-163872
10-K2017-03-14fiscal FY 2016301250001193125-17-081863
10-Q2016-11-14fiscal Q3 201626720001193125-16-767345
10-Q2016-08-15fiscal Q2 201626710001193125-16-681546
10-Q2016-05-16fiscal Q1 201626530001193125-16-591861

Inspect the source

Entity
Syndax Pharmaceuticals, Inc. / CIK 0001395937
Captured
2026-09-20T08:00:02.452Z
SEC response SHA-256
34bb57c63e172e7ddf8a6dc4a5886210e64bd006fb59459f7113dac7ea3f0a8b

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001395937.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))